Cargando…

Clinical significance of evaluating hormone receptor and HER2 protein using cell block against metastatic breast cancer: a multi-institutional study

Hormone receptor and human epidermal growth factor receptor 2 (HER2) protein tests in metastatic breast cancer tissue are recommended in the guidelines of the American Society of Clinical Oncology/American Pathology Association. As part of a multi-institutional study by the National Hospital Organiz...

Descripción completa

Detalles Bibliográficos
Autores principales:	Matsui, Akira, Murata, Yuya, Masuda, Norikazu, Mori, Kiyoshi, Takahashi, Masato, Yamashiro, Katsushige, Aogi, Kenjirou, Maeda, Shigeto, Itou, Masahiro, Ozaki, Shinji, Kuraoka, Kazuya, Satou, Yasuyuki, Ichihara, Shu, Tokunaga, Eriko, Taguchi, Kenichi, Watanabe, Takanori, Suzuki, Hiroyoshi, Nagayama, Aiko, Nishimura, Rieko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2019
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6779284/ https://www.ncbi.nlm.nih.gov/pubmed/31620243 http://dx.doi.org/10.18632/oncotarget.27163

Ejemplares similares

Clinical predictors of pathological complete response to neoadjuvant chemotherapy in triple-negative breast cancer
por: Nakashoji, Ayako, et al.
Publicado: (2017)

Frequency and clinical features of deficient mismatch repair in ovarian clear cell and endometrioid carcinoma
por: Tanaka, Tamaki, et al.
Publicado: (2022)

Comparison of CK-IHC assay on serial frozen sections, the OSNA assay, and in combination for intraoperative evaluation of SLN metastases in breast cancer
por: Shigematsu, Hideo, et al.
Publicado: (2017)

Clinicopathological predictors of postoperative upstaging to invasive ductal carcinoma (IDC) in patients preoperatively diagnosed with ductal carcinoma in situ (DCIS): a multi-institutional retrospective cohort study
por: Tanaka, Kiyo, et al.
Publicado: (2021)

Unmet Information Needs and Quality of Life in Young Breast Cancer Survivors in Japan
por: Miyashita, Mika, et al.
Publicado: (2015)

Long-Term Outcomes of a Randomized Study of Neoadjuvant Induction Dual HER2 Blockade with Trastuzumab and Lapatinib Followed by Weekly Paclitaxel Plus Dual HER2 Blockade for HER2-Positive Primary Breast Cancer (Neo-Lath Study)
por: Tokunaga, Eriko, et al.
Publicado: (2021)

Evaluation of Local Retinal Function in Light-Damaged Rats Using Multifocal Electroretinograms and Multifocal Visual Evoked Potentials
por: Takita, Yuya, et al.
Publicado: (2023)

Survival Outcomes of Retreatment with Trastuzumab and Cytotoxic Chemotherapy for HER2-Positive Recurrent Patients With Breast Cancer Who Had Been Treated with Neo/adjuvant Trastuzumab Plus Multidrug Chemotherapy: A Japanese Multicenter Observational Study
por: Yamashiro, Hiroyasu, et al.
Publicado: (2018)

Clinical usefulness of eribulin as first- or second-line chemotherapy for recurrent HER2-negative breast cancer: a randomized phase II study (JBCRG-19)
por: Aogi, Kenjiro, et al.
Publicado: (2021)

Correction to: Clinical usefulness of eribulin as first- or second-line chemotherapy for recurrent HER2-negative breast cancer: a randomized phase II study (JBCRG-19)
por: Aogi, Kenjiro, et al.
Publicado: (2021)

Correction to: Clinical usefulness of eribulin as first- or second-line chemotherapy for recurrent HER2-negative breast cancer: a randomized phase II study (JBCRG-19)
por: Aogi, Kenjiro, et al.
Publicado: (2022)

Young adult breast cancer patients have a poor prognosis independent of prognostic clinicopathological factors: a study from the Japanese Breast Cancer Registry
por: Kataoka, Akemi, et al.
Publicado: (2016)

Comparison of an AC‐taxane versus AC‐free regimen and paclitaxel versus docetaxel in patients with lymph node‐positive breast cancer: Final results of the National Surgical Adjuvant Study of Breast Cancer 02 trial, a randomized comparative phase 3 study
por: Watanabe, Toru, et al.
Publicado: (2017)

Fulvestrant with or without anti‐HER2 therapy in patients in a postmenopausal hormonal state and with ER‐positive HER2‐positive advanced or metastatic breast cancer: A subgroup analysis of data from the Safari study (JBCRG‐C06)
por: Masuyama, Misato, et al.
Publicado: (2023)

Diagnostic and therapeutic challenges of glioblastoma as an initial malignancy of constitutional mismatch repair deficiency (CMMRD): two case reports and a literature review
por: Onishi, Shumpei, et al.
Publicado: (2023)

Impact of serum vitamin D on the response and prognosis in breast cancer patients treated with neoadjuvant chemotherapy
por: Tokunaga, Eriko, et al.
Publicado: (2021)

Pretreatment risk factors for parametrial involvement in FIGO stage IB1 cervical cancer
por: Yamazaki, Hiroyuki, et al.
Publicado: (2015)

Persistent homology index as a robust quantitative measure of immunohistochemical scoring
por: Takiyama, Akihiro, et al.
Publicado: (2017)

Implications of para-aortic lymph node metastasis in patients with endometrial cancer without pelvic lymph node metastasis
por: Todo, Yukiharu, et al.
Publicado: (2017)

Factors associated with prolonged overall survival in patients with postmenopausal estrogen receptor-positive advanced breast cancer using real-world data: a follow-up analysis of the JBCRG-C06 Safari study
por: Kawaguchi, Hidetoshi, et al.
Publicado: (2019)

Safety, pharmacokinetics and efficacy findings in an open-label, single-arm study of weekly paclitaxel plus lapatinib as first-line therapy for Japanese women with HER2-positive metastatic breast cancer
por: Inoue, Kenichi, et al.
Publicado: (2015)

Elective Cesarean Section during Preterm Prevents Pulmonary Hypoplasia Development in Potter Sequence
por: Kinoshita, Yuya, et al.
Publicado: (2023)

The clinical usefulness of the CTS5 in the prediction of late distant recurrence in postmenopausal women with estrogen receptor-positive early breast cancer
por: Tajiri, Wakako, et al.
Publicado: (2020)

Managing Seroma Formation Post Breast Surgery through Somatostatin Analogs
por: Nagayama, Aiko, et al.
Publicado: (2023)

Isolated tumor cells and micrometastases in regional lymph nodes in stage I to II endometrial cancer
por: Todo, Yukiharu, et al.
Publicado: (2016)

Incidence of metastasis in circumflex iliac nodes distal to the external iliac nodes in cervical cancer
por: Takeshita, Sho, et al.
Publicado: (2016)

The comparison of the anatomic stage and pathological prognostic stage according to the AJCC 8th edition for the prognosis in Japanese breast cancer patients: data from a single institution
por: Tokunaga, Eriko, et al.
Publicado: (2020)

Endobiliary radiofrequency ablation through an EUS-guided hepaticogastrostomy fistula for hilar malignant biliary stenosis
por: Kuraoka, Naosuke, et al.
Publicado: (2021)

Efficacy and safety of pegfilgrastim biosimilar MD‐110 in patients with breast cancer receiving chemotherapy: Single‐arm phase III
por: Takano, Toshimi, et al.
Publicado: (2023)

A case of unusually persistent traumatic intrapulmonary hematoma
por: Kawagishi, Sachi, et al.
Publicado: (2021)

Long-term survival of patients with recurrent endometrial stromal sarcoma: a multicenter, observational study
por: Yamazaki, Hiroyuki, et al.
Publicado: (2015)

A prediction model of survival for patients with bone metastasis from uterine cervical cancer
por: Matsumiya, Hiroko, et al.
Publicado: (2016)

Mediastinal basaloid carcinoma arising from thymic cysts in two dogs
por: SANO, Yuto, et al.
Publicado: (2021)

Glyceraldehyde-derived pyridinium (GLAP) evokes oxidative stress and inflammatory and thrombogenic reactions in endothelial cells via the interaction with RAGE
por: Matsui, Takanori, et al.
Publicado: (2015)

Efficacy, safety, and biomarker analysis of nivolumab in combination with abemaciclib plus endocrine therapy in patients with HR-positive HER2-negative metastatic breast cancer: a phase II study (WJOG11418B NEWFLAME trial)
por: Masuda, Jun, et al.
Publicado: (2023)

A prospective analysis of two studies that used the 5-mm interval slices and 5-mm margin-free method for ipsilateral breast tumor recurrence after breast-conserving surgery without radiotherapy
por: Ohsumi, Shozo, et al.
Publicado: (2022)

CD44v9 as a poor prognostic factor of triple-negative breast cancer treated with neoadjuvant chemotherapy
por: Tokunaga, Eriko, et al.
Publicado: (2018)

Development and evaluation of a novel antibody-photon absorber conjugate reveals the possibility of photoimmunotherapy-induced vascular occlusion during treatment in vivo
por: Isoda, Yuya, et al.
Publicado: (2018)

Changes in Recurrence Score by neoadjuvant endocrine therapy of breast cancer and their prognostic implication
por: Ueno, Takayuki, et al.
Publicado: (2019)

Simultaneous Expression of T‐Cell and Myeloid Cell Phenotypes in Eight Newly Established HTLV‐I‐positive T‐Cell Lines
por: Koizumi, Shigeki, et al.
Publicado: (1992)

Cannot write session to /tmp/vufind_sessions/sess_pu2ku332f8egq5q53d2fceseue